BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 21483254)

  • 1. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.
    Milanesi A; Yu R; Geller SA; Burton D; Deftos LJ; Wolin EM
    Pancreas; 2011 May; 40(4):634-7. PubMed ID: 21483254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.
    Srirajaskanthan R; McStay M; Toumpanakis C; Meyer T; Caplin ME
    Neuroendocrinology; 2009; 89(1):48-55. PubMed ID: 18679021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.
    Milanesi A; Yu R; Wolin EM
    Pancreatology; 2013; 13(3):324-6. PubMed ID: 23719609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone-related peptide mediates hypercalcemia in an islet cell tumor of the pancreas.
    Mitlak BH; Hutchison JS; Kaufman SD; Nussbaum SR
    Horm Metab Res; 1991 Jul; 23(7):344-6. PubMed ID: 1663481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis.
    Dionisi S; Minisola S; Pepe J; De Geronimo S; Paglia F; Memeo L; Fitzpatrick LA
    Mayo Clin Proc; 2002 Aug; 77(8):866-9. PubMed ID: 12173721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
    Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hyperparathyroidism and familial hyperparathyroid syndromes.
    Blackburn M; Diamond T
    Aust Fam Physician; 2007 Dec; 36(12):1029-33. PubMed ID: 18075629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell endometrial cancer.
    Richey DS; Welch BJ
    South Med J; 2008 Dec; 101(12):1266-8. PubMed ID: 19005452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary hyperparathyroidism in special situations: multiple endocrine neoplasia syndromes and parathyroid cancer].
    Quesada Charneco M
    Endocrinol Nutr; 2009 Apr; 56 Suppl 1():35-40. PubMed ID: 19627759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Patient with Persistent Lactation and Recurrent Hypercalcemia.
    Meng QH; Wagar EA
    Clin Chem; 2015 Nov; 61(11):1328-31. PubMed ID: 26511349
    [No Abstract]   [Full Text] [Related]  

  • 11. Parathyroid hormone-related peptide and primary hyperparathyroidism.
    Testini M; Gurrado A; Lissidini G; Piccinni G; Greco L; Basile F; Biondi A
    Front Biosci (Schol Ed); 2010 Jan; 2(1):299-312. PubMed ID: 20036948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone-related protein and hypercalcemia in pancreatic neuro-endocrine tumors.
    Rizzoli R; Sappino AP; Bonjour JP
    Int J Cancer; 1990 Sep; 46(3):394-8. PubMed ID: 2394507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone related protein (PTHrP) mediated hypercalcaemia complicating enteropancreatic malignancy in multiple endocrine neoplasia type 1 (MEN 1).
    Burgess JR; Wilkinson S; Lowenthal RM
    Aust N Z J Med; 2000 Apr; 30(2):280-1. PubMed ID: 10833127
    [No Abstract]   [Full Text] [Related]  

  • 14. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
    Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
    J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton.
    Stewart AF
    J Bone Miner Res; 2002 May; 17(5):758-62. PubMed ID: 12009005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Endocrine Neoplasia Type 1-Related Acute Pancreatitis.
    Takahashi S; Kamimura K; Abe H; Watanabe Y; Hayashi K; Mizuno K; Yamamoto T; Takeuchi M; Natsui M; Terai S
    Pancreas; 2019; 48(5):e35-e38. PubMed ID: 31090663
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
    Fritchie K; Zedek D; Grenache DG
    Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel parathyroid hormone-related gene product.
    Martin TJ; Danks JA
    Henry Ford Hosp Med J; 1989; 37(3-4):187-9. PubMed ID: 2576961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy).
    Sato K
    Endocr J; 2008 Dec; 55(6):959-66. PubMed ID: 18614854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case.
    Omi Y; Horiuchi K; Haniu K; Tokura M; Nagai E; Isozaki O; Nagashima Y; Okamoto T
    Endocr J; 2018 Feb; 65(2):245-252. PubMed ID: 29225207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.